Al Charest

2.3k total citations · 1 hit paper
20 papers, 1.2k citations indexed

About

Al Charest is a scholar working on Molecular Biology, Cancer Research and Genetics. According to data from OpenAlex, Al Charest has authored 20 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 7 papers in Cancer Research and 5 papers in Genetics. Recurrent topics in Al Charest's work include Glioma Diagnosis and Treatment (5 papers), PI3K/AKT/mTOR signaling in cancer (5 papers) and Extracellular vesicles in disease (4 papers). Al Charest is often cited by papers focused on Glioma Diagnosis and Treatment (5 papers), PI3K/AKT/mTOR signaling in cancer (5 papers) and Extracellular vesicles in disease (4 papers). Al Charest collaborates with scholars based in United States, France and Mexico. Al Charest's co-authors include Jaime Acquaviva, Ricky Ngok‐Shun Wong, David E. Housman, Roderick T. Bronson, Ralph Weissleder, Steve Woolfenden, Haihao Zhu, Eric C. Holland, Dolores Hambardzumyan and Luis F. Parada and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Immunology and The Journal of Immunology.

In The Last Decade

Al Charest

17 papers receiving 1.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Single-cell RNA sequencing reveals evolution of immune landscape during glioblastoma progression

2022 153 citations Alan T. Yeo, Shruti Rawal et al. Nature Immunology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Al Charest United States	14	761	352	307	299	223	20	1.2k
Amanda Katz United States	10	689 0.9×	346 1.0×	410 1.3×	303 1.0×	125 0.6×	19	1.2k
Cécile L. Maire Germany	26	964 1.3×	525 1.5×	384 1.3×	582 1.9×	176 0.8×	48	1.8k
Elena I. Fomchenko United States	13	773 1.0×	388 1.1×	605 2.0×	582 1.9×	139 0.6×	23	1.5k
Rolf Warta Germany	21	532 0.7×	324 0.9×	335 1.1×	347 1.2×	226 1.0×	53	1.2k
James S. Hale United States	18	663 0.9×	362 1.0×	411 1.3×	309 1.0×	164 0.7×	30	1.2k
Shannon Matheny United States	11	451 0.6×	389 1.1×	306 1.0×	225 0.8×	202 0.9×	36	1.0k
Dirk Kemming Germany	15	683 0.9×	504 1.4×	423 1.4×	312 1.0×	159 0.7×	22	1.3k
Demirkan Gursel United States	19	491 0.6×	284 0.8×	270 0.9×	243 0.8×	104 0.5×	32	970
Kelly Burrell Canada	18	803 1.1×	254 0.7×	191 0.6×	398 1.3×	133 0.6×	26	1.5k
Verlene Henry United States	14	544 0.7×	290 0.8×	473 1.5×	446 1.5×	124 0.6×	17	1.2k

Countries citing papers authored by Al Charest

Since Specialization

Citations

This map shows the geographic impact of Al Charest's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Al Charest with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Al Charest more than expected).

Fields of papers citing papers by Al Charest

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Al Charest. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Al Charest. The network helps show where Al Charest may publish in the future.

Co-authorship network of co-authors of Al Charest

This figure shows the co-authorship network connecting the top 25 collaborators of Al Charest. A scholar is included among the top collaborators of Al Charest based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Al Charest. Al Charest is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Paulo, João A., Xinyue Liu, A. N. Nguyen, et al.. (2025). Heterogeneity of Extracellular Vesicles and Non‐Vesicular Nanoparticles in Glioblastoma. Journal of Extracellular Vesicles. 14(10). e70168–e70168.

Paulo, João A., Tomer M. Yaron, Jared L. Johnson, et al.. (2024). Pleiotropic tumor suppressive functions of PTEN missense mutations during gliomagenesis. iScience. 27(12). 111278–111278.

Yeo, Alan T., Rinku Pal, Shruti Rawal, et al.. (2023). Driver Mutations Dictate the Immunologic Landscape and Response to Checkpoint Immunotherapy of Glioblastoma. Cancer Immunology Research. 11(5). 629–645. 15 indexed citations

Piranlioglu, Raziye, Ryuhjin Ahn, Hiroshi Nakashima, et al.. (2023). Assessment of The Impact of Oncolytic Virotherapy on The Immunopeptidome Profile of Tumor by Utilizing GEMM Derived Immunocompetent GBM Models. The Journal of Immunology. 210(Supplement_1). 245.11–245.11.

Yeo, Alan T., Shruti Rawal, Bethany Delcuze, et al.. (2022). Single-cell RNA sequencing reveals evolution of immune landscape during glioblastoma progression. Nature Immunology. 23(6). 971–984. 153 indexed citations breakdown →

Yeo, Alan T., Hyun Jung Jun, Vicky A. Appleman, et al.. (2021). EGFRvIII tumorigenicity requires PDGFRA co-signaling and reveals therapeutic vulnerabilities in glioblastoma. Oncogene. 40(15). 2682–2696. 16 indexed citations

Charest, Al. (2020). Experimental and Biological Insights from Proteomic Analyses of Extracellular Vesicle Cargos in Normalcy and Disease. Advanced Biosystems. 4(12). e2000069–e2000069. 11 indexed citations

Vidal, Bárbara, et al.. (2019). A high-grade glioma with SOS1 amplification. Clinical Neuropathology. 39(5). 126–134. 1 indexed citations

Navarrete-Perea, José, Ala Jo, Simona Cristea, et al.. (2019). Physical and Molecular Landscapes of Mouse Glioma Extracellular Vesicles Define Heterogeneity. Cell Reports. 27(13). 3972–3987.e6. 54 indexed citations

10.

Zhou, Shuang, Vicky A. Appleman, Christopher M. Rose, et al.. (2018). Chronic platelet-derived growth factor receptor signaling exerts control over initiation of protein translation in glioma. Life Science Alliance. 1(3). e201800029–e201800029. 5 indexed citations

11.

Ricklefs, Franz, Marco Mineo, Arun K. Rooj, et al.. (2016). Extracellular Vesicles from High-Grade Glioma Exchange Diverse Pro-oncogenic Signals That Maintain Intratumoral Heterogeneity. Cancer Research. 76(10). 2876–2881. 81 indexed citations

12.

Jun, Hyun Jung, Jeremy Roy, Tegan Smith, et al.. (2014). ROS1 Signaling Regulates Epithelial Differentiation in the Epididymis. Endocrinology. 155(9). 3661–3673. 29 indexed citations

13.

Hambardzumyan, Dolores, Luis F. Parada, Eric C. Holland, & Al Charest. (2011). Genetic modeling of gliomas in mice: New tools to tackle old problems. Glia. 59(8). 1155–1168. 74 indexed citations

14.

Zhu, Haihao, Steve Woolfenden, Roderick T. Bronson, et al.. (2010). The Novel Hsp90 Inhibitor NXD30001 Induces Tumor Regression in a Genetically Engineered Mouse Model of Glioblastoma Multiforme. Molecular Cancer Therapeutics. 9(9). 2618–2626. 28 indexed citations

15.

Daniel, Karen, Grace Kim, Christophoros C. Vassiliou, et al.. (2009). Implantable diagnostic device for cancer monitoring. Biosensors and Bioelectronics. 24(11). 3252–3257. 46 indexed citations

16.

Woolfenden, Steve, Haihao Zhu, & Al Charest. (2009). A Cre/LoxP conditional luciferase reporter transgenic mouse for bioluminescence monitoring of tumorigenesis. genesis. 47(10). 659–666. 16 indexed citations

17.

Zhu, Haihao, Jaime Acquaviva, Abraham Boskovitz, et al.. (2009). Oncogenic EGFR signaling cooperates with loss of tumor suppressor gene functions in gliomagenesis. Proceedings of the National Academy of Sciences. 106(8). 2712–2716. 172 indexed citations

18.

Acquaviva, Jaime, Ricky Ngok‐Shun Wong, & Al Charest. (2008). The multifaceted roles of the receptor tyrosine kinase ROS in development and cancer. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 1795(1). 37–52. 151 indexed citations

19.

Mills, John R., Yoshitaka Hippo, Françis Robert, et al.. (2008). mTORC1 promotes survival through translational control of Mcl-1. Proceedings of the National Academy of Sciences. 105(31). 10853–10858. 229 indexed citations

20.

Charest, Al, Erik Wilker, Margaret E. McLaughlin, et al.. (2006). ROS Fusion Tyrosine Kinase Activates a SH2 Domain–Containing Phosphatase-2/Phosphatidylinositol 3-Kinase/Mammalian Target of Rapamycin Signaling Axis to Form Glioblastoma in Mice. Cancer Research. 66(15). 7473–7481. 120 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact